These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


284 related items for PubMed ID: 3073869

  • 1. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A, Fattovich G, Pontisso P, Brollo L, Belussi F, Ruol A.
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
    Krastev Z, Jelev D, Antonov K, Alagozian V, Kotzev I.
    Hepatogastroenterology; 1999 Dec; 46(30):3184-8. PubMed ID: 10626183
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
    Mazzella G, Saracco G, Rizetto M, Amed MA, Gonzàlez Quintela A, Rosina F, Barbara L, Roda E.
    Am J Med; 1988 Aug 29; 85(2A):141-2. PubMed ID: 3044077
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.
    Int J Mol Med; 2002 Aug 29; 10(2):201-4. PubMed ID: 12119559
    [Abstract] [Full Text] [Related]

  • 9. Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon.
    Giacchino R, Facco F, Giambartolomei G, Navone C, Timitilli A, Cirillo C, Barigione G, Terragna A.
    Chemioterapia; 1988 Dec 29; 7 Suppl 3():20-5. PubMed ID: 3073870
    [Abstract] [Full Text] [Related]

  • 10. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan 29; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov 29; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 13. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C.
    Turk J Gastroenterol; 2004 Mar 29; 15(1):14-20. PubMed ID: 15264116
    [Abstract] [Full Text] [Related]

  • 14. Low level wild-type and pre-core mutant hepatitis B viruses and HBeAg negative reactivation of chronic hepatitis B.
    Oketani M, Oketani K, Xiaohong C, Arima T.
    J Med Virol; 1999 Aug 29; 58(4):332-7. PubMed ID: 10421398
    [Abstract] [Full Text] [Related]

  • 15. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M, Jardi R, Rodriguez-Frias F, Allende H, Cotrina M, Esteban R, Guardia J.
    J Med Virol; 1996 Aug 29; 49(4):325-8. PubMed ID: 8877766
    [Abstract] [Full Text] [Related]

  • 16. Interferon in chronic active hepatitis B. Preliminary results.
    Waked I, Amin M, Abd-el Fattah SA, Osman L, Sabbour M.
    Chemioterapia; 1988 Jun 29; 7(3):198-202. PubMed ID: 3168077
    [Abstract] [Full Text] [Related]

  • 17. Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole.
    Fattovich G, Giustina G, Brollo L, Guido M, Pontisso P, Noventa F, Alberti A.
    Hepatology; 1992 Nov 29; 16(5):1115-9. PubMed ID: 1427652
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels.
    Cabrerizo M, Bartolomé J, Iñigo ER, López-Alcorocho JM, Cotonat T, Carreño V.
    J Med Virol; 1998 Dec 29; 56(4):294-9. PubMed ID: 9829632
    [Abstract] [Full Text] [Related]

  • 19. Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B.
    Yuen MF, Ng IO, Fan ST, Yuan HJ, Wong DK, Yuen JC, Sum SS, Chan AO, Lai CL.
    Am J Gastroenterol; 2004 Oct 29; 99(10):2032-7. PubMed ID: 15447768
    [Abstract] [Full Text] [Related]

  • 20. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH, Song BC, Lee GC, Shin JW, Ryu SH, Jung SA, Yoo K, Lee HC, Lee YS, Suh DJ.
    Eur J Gastroenterol Hepatol; 2003 May 29; 15(5):489-93. PubMed ID: 12702905
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.